Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polyclonal Anti-D Antibodies Significantly Reduce the Rate of Miscarriages in Rh(D) positive Women with Recurrent Pregnancy loss. | Obstet Gynecol Res | 2023 | 37168076 | PubTator, text mining | PubMed |
| In vitro comparison of cold-stored whole blood and reconstituted whole blood. | Vox Sang | 2023 | 37166393 | PubTator, text mining | PubMed |
| A draft human pangenome reference. | Nature | 2023 | 37165242 | PubTator, text mining | PubMed |
| Establishment and application of suspension static method in blood group screening of automated blood group analyzer. | Sci Rep | 2023 | 37160939 | PubTator, text mining | PubMed |
| Red Blood Cell Alloimmunization and Autoimmunization in Blood Transfusion-Dependent Sickle Cell Disease and β-Thalassemia Patients in Al-Ahsa Region, Saudi Arabia. | Anemia | 2023 | 37152479 | PubTator, text mining | PubMed |
| Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China. | Front Pediatr | 2023 | 37124190 | PubTator, text mining | PubMed |
| RHD Positive Haplotype in D Negative Omani Blood Donor. | Oman Med J | 2023 | 37122416 | PubTator, text mining | PubMed |
| Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey. | Transfus Clin Biol | 2023 | 37116742 | PubTator, text mining | PubMed |
| Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients. | Front Pediatr | 2023 | 37114005 | PubTator, text mining | PubMed |
| Association of ABO and RhD blood groups with the risk of HIV infection. | PLoS One | 2023 | 37099490 | PubTator, text mining | PubMed |
| Generation of Rh D-negative blood using CRISPR/Cas9. | Cell Prolif | 2023 | 37096780 | PubTator, text mining | PubMed |
| Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation. | PLoS One | 2023 | 37093806 | PubTator, text mining | PubMed |
| RHD*DNT (RHD*38) Showing D-Positive Reactivity on Rhesus D Typing and Forming Anti-D Antibody. | Ann Lab Med | 2023 | 37080757 | PubTator, text mining | PubMed |
| Pre-transfusion Testing Using Crossmatching Agglutination Reaction Grades Combined With Rh Subgroup Phenotyping in Patients With Autoantibodies: A Three-year Experience at a Tertiary Hospital. | Ann Lab Med | 2023 | 37080748 | PubTator, text mining | PubMed |
| Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia. | Int J Womens Health | 2023 | 37077284 | PubTator, text mining | PubMed |
| Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma. | Transfusion | 2023 | 37070798 | PubTator, text mining | PubMed |
| A rapid ABO and RhD test demonstrates high fidelity to blood bank testing for RhD typing. | Transfusion | 2023 | 37067381 | PubTator, text mining | PubMed |
| Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program. | Transfusion | 2023 | 37067378 | PubTator, text mining | PubMed |
| Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients. | Transfusion | 2023 | 37067374 | PubTator, text mining | PubMed |
| Hemolytic Disease of Newborn due to ABO Incompatibility between B Blood Group Mother and A Blood Group Neonate. | J Lab Physicians | 2023 | 37064992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=29